Abstract
Mild cognitive impairment: a prodromal phase of dementia? Cognitive decline without dementia is common among older persons. A variety of clinical concepts have been introduced in the past 30 years, in order to describe these cognitive deficits arising in older persons. The most frequently used concept is Mild Cognitive Impairment (MCI). MCI is generally seen as a prodromal phase of Alzheimer disease (AD). Several concepts are described, with the neuropsychiatric features and predictors of conversion to dementia c.q. AD. Finally, consequences of preclinically diagnoses for health care are clarified.
Tijdschr Gerontol Geriatr 2007; 38:115-121
Samenvatting
Cognitieve beperkingen zónder dat er sprake is van dementie komen bij ouderen frequent voor. Er zijn om deze cognitieve beperkingen te kunnen definiëren, de afgelopen 30 jaar meerdere klinische concepten in het leven geroepen. Het meest gebruikte en onderzochte concept is MCI (mild cognitive impairment). MCI wordt in het algemeen als het voorstadium van de ziekte van Alzheimer gezien. De verschillende concepten worden besproken, waarbij tevens aandacht besteed zal worden aan begeleidende neuropsychiatrische verschijnselen en predictoren die de kans op conversie naar dementie i.c. de ziekte van Alzheimer verhogen. Tot slot worden de beleidsconsequenties van preklinische diagnostiek van dementie besproken.
This is a preview of subscription content,
to check access.Literatuur
Petersen RC, Smith GE, Warung SC e.a. Mild cognitive impairment. Clinical characterization and outcome. Arch Neurol 1999; 56:303-308.
Unverzagt FW, Gao S, Baiyewu O e.a. Prevalence of cognitive impairment. Data from the Indianapolis Study of Health and Aging. Neurology 2001; 57: 1655-1662
Lopez OL, Jagust WJ, DeKosky ST e.a. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study (CHS): Cognition Study. Arch Neurol 2003a; 60:1385-1389
Dik MG. Cognitive decline in older persons. Contribution of genetics, health and lifestyle. Thesis, VU Medisch Centrum 2002, Amsterdam
Lopez OL, Jagust WJ, Dulberg C e.a. Riskfactors for mild cognitive impairment in the cardiovascular Health Study (CHS): Cognition Study. Arch Neurol 2003b; 60:1394-1399
Kral VA. Senescent forgetfulness: benign and malignant. J Can Med Assoc 1962; 86:257-260
Crook T, Bartus RT, Ferris SH e.a. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group. Developmental Neuropsychology 1986; 2:261-276
Levy R. Aging-associated cognitive decline. Int Psychogeriatrics 1994; 6:63-68
Richards M, Touchon J, Ledésert B e.a. Cognitive decline in ageing: are AAMI and AACD distinct entities? Int J Geriatr Psychiatry 1999; 14:534-540
Graham JE, Rockwood K, B Lynn Beattie e.a. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-1796
Rubin EH, Kinscherf D. Psychopathology of very mild dementia of the Alzheimertype. Am J Psychiatry 1989; 146:1017-1021
Zaudig M A. new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-IIIR criteria. Int Psychogeriatr 1992; suppl 2:203-219.
Petersen RC, Doody R, Kurz A e.a. Current concepts in Mild Cognitive Impairment. Arch Neurol 2001; 58:1985-1992.
Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004; 256:183-194
Visser PJ, Scheltens P, Verhey FRJ. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? J Neurol Neurosurg Psychiatry 2005; 76:1348-1354
Schmand B, Jonker C, Hooijer C e.a. Subjective memory complaints may announce dementia. Neurology 1996; 46:121-125.
Bowen J, Teri L, Kukull W e.a. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349:763-765
Hodges J. The amnestic prodrome of Alzheimer's disease. Brain 1998; 121:1601-1602
Ritchie K & Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355:225-228
Daly E, Zaitchik D, Copeland M e.a. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000; 57:675-680
Chen P, Ratcliff D, Belle SH e.a. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55:1847-1853
Wang QS & Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Research 2002; 924:113-115
Berg L, Hughes CP, Danziger WL e.a. Mild senile dementia of Alzheimertype (SDAT): research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatr 1982; 45:962-968
Ritchie K Artero S, Touchon J. Classification criteria for mild cognitive impairment. A population-based validation study. Neurology 2001; 56:37-42
McKelvey R, Bergman H, Stern J. Lack of prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Can J Neurol 1999; Sci 26:23-28
Bennett DA, Wilson RS, Schneider JA. e.a. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59:198-205
Morris JC, Storandt M, Miller JP e.a. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58:397-405
Tabert MH, Albert SM, Borukhova-Milov L e.a. Functional deficits in patients with mild cognitive impairment. Neurology 2002; 58:758-764
Larrieu S, Letteneur L, Orgogozo JM. e.a. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59:1594-1599
Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003; 61:1179-1184
Ganguli M, Dodge HH, Shen C e.a. Mild cognitive impairment, amnestic type. An epidemiologic study. Neurology 2004; 63:115-121
Comijs HC, Dik MG, Deeg DJH, e.a. The course of cognitive decline in older persons: results from the Longitudinal Aging Study Amsterdam. Dement Geriatr Cogn Disord 2004; 17:136-142
Petry S, Cummings JL, Hill MA e.a. Personality alterations in dementia of the Alzheimer type. A three-year follow-up study. J Geriatr Psychiatry Neurology 1989; 2:203-207
Cummings JL, Mega M, Gray K e.a. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314
Lyketsos CG, Lopez O, Jones B e.a. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA 2002; 288:1475-1483.
Hwang TJ, Masterman DL, Ortiz F e.a. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alz Dis Assoc Disord 2004; 18 :17-21
Feldman H, Scheltens P, Scarpini E e.a. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62:1199-1201
Geerlings MI, Schoevers RA, Beekman ATF e.a. Depression and the risk of cognitive decline and Alzheimer's disease. Br J Psychiat 2000; 176, 568-575.
Ready RE, Ott BR, Grace J. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2003; 11:222-228
Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. A prospective cohort study. Arch Neurol 2004; 61:1290-1293
Tierney MC, Boyle E, Lam E. e.a. Do depressive symptoms in memory-impaired elders predict probable Alzheimer’s disease? Aging & Mental Health 1999; 3:88-93
Jack CR, Petersen RC, Xu YC e.a. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52:1397-1403
Blennow K & Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2003; 2:605-613
Arai H, Nakagawa T, Kosaka T e.a. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals. Alzheimer’s Res 1997; 3:211-213.
Amieva H, Letteneur L, Dartiques JF e.a. Annual rate and predictors of conversion to dementia in subjects presenting with mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004; 18:87-93
Aggarwal NT, Wilson RS, Beck TL e.a. The apolipoprotein E epsilon4 allele and incident Alzheimer’s disease in persons with mild cognitive impairment. Neurocase 2005; 11:3-7
Kryscio RJ, Schmitt FA, Salazar JC e.a. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006; 66:828-832
Visser PJ, Verhey FRJ, Scheltens P e.a. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol 2002; 249:312-319.
Petersen RC, Thomas RG, Grundman M e.a. Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine 2005; 352:2379-2388
Comijs HC, Deeg DJH, Dik MG e.a. Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. J Affective Disord 2002; 72:157-165
Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004; 3:343-353
Author information
Authors and Affiliations
Corresponding author
Additional information
gedragsneuroloog, VU medisch centrum, EMGO Instituut, Amsterdam
senior-onderzoeker, GGZ Buitenamstel/VU medisch centrum, Amsterdam
Correspondentie: Prof. Dr. C. Jonker, VU medisch centrum EMGO Instituut, Van de Boechorststraat 7-9,1081 BT Amsterdam. E-mail:c.jonker@vumc.nl
About this article
Cite this article
Jonker, C., Comijs, H.C. Lichte Cognitieve Stoornissen (MCI): Prodromen van dementie?. GEEG 38, 104–110 (2007). https://doi.org/10.1007/BF03074837
Issue Date:
DOI: https://doi.org/10.1007/BF03074837